Summary
Interim data from the PREVENTION clinical study report improvements in cerebral blood flow and insulin response among people with early Alzheimers disease who received a structured lifestyle and medical support program, compared with standard medical care and general lifestyle recommendations. The …
Source: The Clinical Trial Vanguard
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
